- Home
- NAVI vs GRDN Comparison
NAVI vs GRDN Comparison
Compare NAVI & GRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAVI
- GRDN
- Stock Information
- Founded
- NAVI 1973
- GRDN 2004
- Country
- NAVI United States
- GRDN United States
- Employees
- NAVI N/A
- GRDN N/A
- Industry
- NAVI Investment Bankers/Brokers/Service
- GRDN Retail-Drug Stores and Proprietary Stores
- Sector
- NAVI Finance
- GRDN Consumer Staples
- Exchange
- NAVI Nasdaq
- GRDN Nasdaq
- Market Cap
- NAVI 1.4B
- GRDN 1.3B
- IPO Year
- NAVI N/A
- GRDN 2024
- Fundamental
- Price
- NAVI $14.02
- GRDN $19.62
- Analyst Decision
- NAVI Hold
- GRDN Strong Buy
- Analyst Count
- NAVI 7
- GRDN 2
- Target Price
- NAVI $14.07
- GRDN $22.50
- AVG Volume (30 Days)
- NAVI 901.7K
- GRDN 53.5K
- Earning Date
- NAVI 01-29-2025
- GRDN 03-04-2025
- Dividend Yield
- NAVI 4.57%
- GRDN N/A
- EPS Growth
- NAVI N/A
- GRDN N/A
- EPS
- NAVI 1.18
- GRDN N/A
- Revenue
- NAVI $848,000,000.00
- GRDN $1,170,907,000.00
- Revenue This Year
- NAVI N/A
- GRDN $18.05
- Revenue Next Year
- NAVI N/A
- GRDN $9.55
- P/E Ratio
- NAVI $11.88
- GRDN N/A
- Revenue Growth
- NAVI N/A
- GRDN 16.86
- 52 Week Low
- NAVI $12.73
- GRDN $14.16
- 52 Week High
- NAVI $17.56
- GRDN $25.74
- Technical
- Relative Strength Index (RSI)
- NAVI 53.76
- GRDN N/A
- Support Level
- NAVI $13.70
- GRDN N/A
- Resistance Level
- NAVI $13.70
- GRDN N/A
- Average True Range (ATR)
- NAVI 0.29
- GRDN 0.00
- MACD
- NAVI 0.04
- GRDN 0.00
- Stochastic Oscillator
- NAVI 85.45
- GRDN 0.00
About NAVI Navient Corporation
Navient Corp provides technology-enabled education finance and business processing solutions that simplify complex programs and help millions of people achieve success. It operates business in three segments: Federal Education Loans, Consumer Lending and Business Processing.
About GRDN Guardian Pharmacy Services Inc. Class A Common Stock
Guardian Pharmacy Services Inc is a leading, highly differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs, and .BHFs.